References
Okada T, Noji S, Goto Y, et al. Immune responses to DNA mismatch repair enzymes hMSH2 and hPMS1 in patients with pancreatic cancer, dermatomyositis and polymyositis. Int J Cancer 2005; 116: 925–33.
Casciola-Rosen LA, Pluta AF, Plotz PH, et al. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum 2001; 44: 389–96.
Muro Y, Nakashima R, Hosono Y, et al. Autoantibodies to DNA mismatch repair enzymes in polymyositis/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis. Arthritis Rheumatol 2014; 66: 3457–62.
Muro Y, Sugiura K, Akiyama M. A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement. Clin Dev Immunol 2013; 2013: 856815.
Muro Y, Sugiura K, Mimori T, et al. DNA mismatch repair enzymes: genetic defects and autoimmunity. Clin Chim Acta 2015; 442: 102–9.
Fiorentino D, Chung L, Zwerner J, et al. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 2011; 65: 25–34.
Fujimoto M, Hamaguchi Y, Kaji K, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012; 64: 513–22.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kubo, N., Yanaba, K., Kikuchi, S. et al. Juvenile dermatomyositis positive for anti-DNA mismatch repair enzyme antibodies. Eur J Dermatol 27, 97–99 (2017). https://doi.org/10.1684/ejd.2016.2823
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2016.2823